DAIICHI SANKYO CO. LTD revenue for the last year amounted to 9.81 B EUR, the most of which — 9.33 B EUR — came from its highest performing source at the moment, Prescription Drugs, the year earlier bringing 8.38 B EUR. The greatest contribution to the revenue figure was made by Japan — last year it brought DAIICHI SANKYO CO. LTD 3.67 B EUR, and the year before that — 3.71 B EUR.